Symptomatic Neurogenic Orthostatic Hypotension
📧 Sign up to get email alerts when something new happens for Symptomatic Neurogenic Orthostatic Hypotension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2023-01-20Clinical Trial Update: Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure [Phase 3]
Phase 3 trial of TD-9855 for symptomatic neurogenic orthostatic hypotension was terminated; results were posted in 2023.